Total Skeletal Muscle PGC-1 Deficiency Uncouples Mitochondrial Derangements from Fiber Type Determination and Insulin Sensitivity  by Zechner, Christoph et al.
Cell Metabolism
ArticleTotal Skeletal Muscle PGC-1 Deficiency Uncouples
Mitochondrial Derangements from Fiber Type
Determination and Insulin Sensitivity
Christoph Zechner,1,3,6 Ling Lai,1,3 Juliet F. Zechner,1,3,6 Tuoyu Geng,4,5 Zhen Yan,4,5 John W. Rumsey,3 Deanna Collia,3
Zhouji Chen,1 David F. Wozniak,2 Teresa C. Leone,1,3 and Daniel P. Kelly1,3,*
1Department of Medicine
2Department of Psychiatry
Washington University School of Medicine, St. Louis, MO 63110, USA
3Sanford-Burnham Medical Research Institute, Orlando, FL 32827, USA
4Department of Medicine
5Center for Skeletal Muscle Research at Robert M. Berne Cardiovascular Research Center
University of Virginia School of Medicine, Charlottesville, VA, 22908, USA
6Present address: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
*Correspondence: dkelly@sanfordburnham.org
DOI 10.1016/j.cmet.2010.11.008SUMMARY
Evidence is emerging that the PGC-1 coactivators
serve a critical role in skeletal muscle metabolism,
function, and disease. Mice with total PGC-1 defi-
ciency in skeletal muscle (PGC-1a/bf/f/MLC-Cre
mice) were generated and characterized. PGC-
1a/bf/f/MLC-Cre mice exhibit a dramatic reduction in
exercise performance compared to single PGC-1a-
or PGC-1b-deficient mice and wild-type controls.
The exercise phenotype of the PGC-1a/bf/f/MLC-Cre
mice was associated with a marked diminution in
muscle oxidative capacity, together with rapid deple-
tion of muscle glycogen stores. In addition, the
PGC-1a/b-deficient muscle exhibited mitochondrial
structural derangements consistent with fusion/
fission and biogenic defects. Surprisingly, the propor-
tion of oxidative muscle fiber types (I, IIa) was not
reduced in the PGC-1a/bf/f/MLC-Cre mice. Moreover,
insulin sensitivity and glucose tolerance were not
altered in the PGC-1a/bf/f/MLC-Cre mice. Taken
together, we conclude that PGC-1 coactivators are
necessary for the oxidative and mitochondrial
programs of skeletal muscle but are dispensable for
fundamental fiber type determination and insulin
sensitivity.
INTRODUCTION
The transcriptional coactivators PPARg coactivator-1a (PGC-1a)
and PGC-1b serve as regulators of mitochondrial biogenesis and
cellular energy metabolism (Kelly and Scarpulla, 2004; Lin et al.,
2005). Originally discovered in brown adipose tissue (Puigserver
et al., 1998), PGC-1a enhances transcription by interacting
directly with target transcription factors, including PPARg and
other members of the nuclear receptor superfamily (reviewed inCell MFinck and Kelly, 2006; Handschin and Spiegelman, 2006). The
PGC-1 coactivators are enriched in tissues with high capacity
for mitochondrial respiratory function, such as brown adipose
tissue, heart, and skeletal muscle, and are highly inducible in
response to physiological stimuli, including exercise, fasting,
and cold exposure (Wu et al., 1999; Goto et al., 2000; Lehman
et al., 2000; Baar et al., 2002; Pilegaard et al., 2003; Finck and
Kelly, 2006).
Evidence is emerging that PGC-1 signaling plays an important
role in skeletal muscle structure and function (Lin et al., 2002a;
Arany et al., 2005, 2007; Leone et al., 2005; Lelliott et al., 2006;
Handschin et al., 2007). Tissue-specific transgenic approaches
in mice have shown that forced overexpression of PGC-1 coac-
tivators in skeletal muscle increases muscle oxidative capacity
and the proportions of type I and IIa fibers (Lin et al., 2002a).
PGC-1b has been shown to drive formation of type IIx fibers
(Arany et al., 2007). Using a skeletal-muscle-specific, doxycy-
cline-regulated system, we found that acute induction of
PGC-1a expression in mice increased muscle glycogen stores,
a signature of training (Wende et al., 2007). Collectively, the
results of the forced expression studies suggest that induction
of PGC-1a, which is known to occur following exercise, drives
a trained skeletal muscle phenotype. However, gain-of-function
studies have not defined the role of PGC-1 coactivators in funda-
mental skeletal muscle development, fiber type specification, or
mitochondrial biogenesis. Insights gained from PGC-1 coactiva-
tor mouse ‘‘knockout’’ studies to date have been limited due to
the functionally redundant actions of PGC-1a and PGC-1b;
single PGC-1 gene deletion lines exhibit relatively minimal
phenotypes (Lin et al., 2004; Leone et al., 2005; Lelliott et al.,
2006; Vianna et al., 2006; Sonoda et al., 2007). Mice with gener-
alized combined deficiency of PGC-1a and PGC-1b
(PGC-1ab/ mice) die of severe heart failure shortly after birth,
precluding evaluation of the skeletal muscle phenotype in this
model (Lai et al., 2008).
Recently, dysregulation of PGC-1 coactivators has been impli-
cated in the development of skeletal muscle insulin resistance
(Mootha et al., 2003; Patti et al., 2003), although this notion is
controversial. Single PGC-1a or PGC-1b ‘‘knockout’’ mouseetabolism 12, 633–642, December 1, 2010 ª2010 Elsevier Inc. 633
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Figure 1. Global Loss of PGC-1a Combined with Muscle-Specific
Loss of PGC-1b Results in a Dramatic Exercise Performance Deficit
Two- to three-month-old male PGC-1bf/f (ab+/+), PGC-1a/bf/f (a/),
PGC-1bf/f/MLC-Cre (b/), and PGC-1a/bf/f/MLC-Cre (ab/) mice were sub-
jected to a run-to-exhaustion protocol on a motorized treadmill (n = 6–7) as
described in Experimental Procedures. Bars represent mean running time
(± SEM) in minutes. *p < 0.05 versus ab+/+; zp < 0.05 versus a/; #p < 0.05
versus b/. See also Figure S1.
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PGC-1 Actions in Skeletal Musclemodels have generally not demonstrated insulin-resistant or
glucose-intolerant phenotypes (Lin et al., 2004; Leone et al.,
2005; Lelliott et al., 2006; Vianna et al., 2006; Sonoda et al.,
2007). Again, the difficulty in interpreting these studies relates
to the functional overlap between the PGC-1 coactivators,
setting the stage for compensatory or even supercompensatory
responses by the remaining coactivator.
Given the importance of PGC-1 coactivators inmuscle biology
and their potential role in the metabolic basis of disease, we em-
barked on a study to define the necessary functions of these
regulatory factors in skeletal muscle using a conditional loss-
of-function strategy in mice. To this end, a gene-targeting
approach was used to establish mice with skeletal-muscle-
specific PGC-1b deficiency on a generalized PGC-1a-deficient
background. We found that combined deficiency of PGC-1a
and PGC-1b in skeletal muscle results in a dramatic exercise
performance phenotype related to mitochondrial structural and
functional abnormalities. Surprisingly, PGC-1a/bf/f/MLC-Cre
mice did not exhibit a defect in fundamental muscle fiber type
formation or abnormalities in glucose tolerance or insulin
sensitivity.
RESULTS
Dramatic Exercise Deficit in Mice with Muscle
PGC-1a/b Deficiency
The PGC-1b gene was disrupted via loxP-mediated excision in
skeletal muscle by Cre recombinase (Cre) expressed under the
control of the myosin light chain 1f (MLC1f) promoter (PGC-
1bf/f/MLC-Cre mice) (Figure S1A). Consistent with the type II fiber
specificity of the MLC-1f promoter (Donoghue et al., 1991;
Parsons et al., 2004), PGC-1b gene expression was markedly
reduced in gastrocnemius (GC) (residual levels 10.9% ± 1.3%
of PGC-1bf/f) and white vastus (9.0% ± 1.5% of PGC-1bf/f)
muscles of PGC-1bf/f/MLC-Cre mice, but to a lesser extent in
soleus muscle (44% ± 8.5% of PGC-1bf/f) (Figure S1B), which
contains a greater proportion of type I fibers. Immunoblotting
studies confirmed that PGC-1b protein levels were undetectable
in primary cells derived fromGCmuscle of PGC-1a/bf/f/MLC-Cre
mice (Figure S1C). PGC-1b gene expression was not reduced in
heart or liver in the PGC-1bf/f/MLC-Cre mice (Figure S1B). PGC-1a
mRNA levels were unchanged in the muscle of the PGC-
1bf/f/MLC-Cre mice (data not shown). PGC-1bf/f/MLC-Cre mice
survived, appeared normal compared to WT littermates, and
did not exhibit overt abnormalities in locomotor activity. To
generate lines with skeletal muscle deficiency of both PGC-1a
and PGC-1b, the PGC-1bf/f/MLC-Cre mice were crossed into
a generalized PGC-1a/ background (Leone et al., 2005),
a strategy that was used previously to generate mice with
combined deficiency of PGC-1a and PGC-1b in heart (Lai
et al., 2008). Mice with combined PGC-1a and PGC-1b defi-
ciency in skeletal muscle (PGC-1a/bf/f/MLC-Cre mice) were
viable, appeared normal on inspection, and did not exhibit any
overt abnormalities in locomotor activity. Fasting circulating
triglyceride and glucose levels were not abnormal in the PGC-
1a/bf/f/MLC-Cre mice (data not shown).
We and others have shown that PGC-1a-deficient mice exhibit
a mild exercise performance phenotype (Leone et al., 2005;
Handschin et al., 2007; Lai et al., 2008). To define the impact634 Cell Metabolism 12, 633–642, December 1, 2010 ª2010 Elsevierof muscle-specific PGC-1b deficiency and combined PGC-
1a/PGC-1b deficiency on exercise performance, the PGC-
1bf/f/MLC-Cre and PGC-1a/bf/f/MLC-Cre mice were subjected to
a low-intensity run-to-exhaustion protocol on a motorized tread-
mill. Compared to the performance of ‘‘floxed’’ controls (170.2 ±
7.1 min), PGC-1a/bf/f and PGC-1bf/f/MLC-Cre mice demon-
strated a mild but significant performance deficit (mean running
times of 114 ± 7.1 min and 140 ± 8.8 min, respectively) (Figure 1).
In striking contrast, PGC-1a/bf/f/MLC-Cre mice exhibited
a dramatic exercise phenotype, showing exhaustion after an
average of only 6.6 ± 1.6 min (Figure 1).
Histological assessment of the GC muscle of PGC-1a/
bf/f/MLC-Cre mice did not reveal any overt cellular derangements
or fibrosis (Figure S1D and data not shown). However, a very
slight increase in the proportion of myocytes with centralized
nuclei was noted in PGC-1a/bf/f/MLC-Cre muscle fibers, indica-
tive of increased muscle fiber regeneration (Figure S1E). As
a measure of muscle damage, circulating creatine kinase (CK)
was assayed in PGC-1a/bf/f/MLC-Cre mice and controls
30 min following a bout of exercise (protocol described in
Supplemental Experimental Procedures). Mean plasma CK
levels were mildly but significantly elevated in PGC-1a/
bf/f/MLC-Cre mice compared to the other groups (bf/f, 24.0 ±
3.5 U/l; a/bf/f, 23.5 ± 2.3 U/l; bf/f/MLC-Cre, 31.1 ± 6.3 U/l;
a/bf/f/MLC-Cre, 103 ± 37.4 U/l; p < 0.004), possibly consistent
with mild skeletal muscle injury. Taken together, these results
are unlikely to account for the profound exercise performance
deficit of the PGC-1a/bf/f/MLC-Cre line.
The exercise phenotype of the PGC-1a/bf/f/MLC-Cre mice
prompted us to assess general ambulatory activity and other
parameters that may influence ambulation and exercise perfor-
mance. Using a 1 hr locomotor activity test, both PGC-1a/bf/f
and PGC-1a/bf/f/MLC-Cre lines exhibited a similar, modest
decrease in total ambulations (whole-body movements)
compared to the PGC-1bf/f group (Figure S1F, left). Time spent in
the central and peripheral zones of the test area, as a measure of
exploratory behavior, was also recorded and analyzed. PGC-
1a/bf/f and PGC-1a/bf/f/MLC-Cre mice traveled significantly
shorter distances within the peripheral zone (Figure S1F, middle)
and entered the center less frequently (Figure S1F, right) whenInc.
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Figure 2. PGC-1a–/–bf/f/MLC-Cre Muscle
Exhibits an Increase in MHC1-Positive
Fibers without a Change in Type II Fiber
Distribution
(A) Cross-sections of gastrocnemius (Gastroc)
muscle of 3- to 6-month-old male PGC-1bf/f
(ab+/+), PGC-1a/bf/f (a/), PGC-1bf/f/MLC-Cre
(b/), and PGC-1a/bf/f/MLC-Cre (ab/) mice
(n = 5–6) stained for myosin I ATPase activity.
Type I (MHC1-positive) fibers are stained dark.
See also Figure S2.
(B) Top: Sections of plantaris muscle of 3- to
4-month-old male mice (n = 5–7) were immuno-
stained for MHC1 (red), MHC2a (blue), and
MHC2b (green). Representative images are
shown. Scale bars denote 200 mm. Bottom: Quan-
tification results of the plantaris muscle MHC im-
munostaining studies expressed as mean percent
(± SEM) of total muscle fibers. Unstained muscle
fibers were counted as MHC2x positive. Insert
shows magnification of MHC1 results. *p < 0.05
versus ab+/+; zp < 0.05 versus a/; #p < 0.05
versus b/.
(C) Succinate dehydrogenase (SDH) activity stain-
ing was performed on sections of gastrocnemius
muscle (top row; n = 5–6) and soleus muscle
(bottom row; n = 2) of 3- to 6-month-old male
mice of the indicated genotypes.
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PGC-1 Actions in Skeletal Musclecompared to the PGC-1bf/f group. These collective results are
consistent with our earlier findings that PGC-1a deficiency results
in a mild decrease in general ambulatory activity and may induce
emotional disturbances (Leone et al., 2005). However, this pheno-
type was not more severe in the PGC-1a/bf/f/MLC-Cre mice.
Interestingly, muscle strength, as assessed by forelimb grip
studies, did not reveal differences between groups (Figure S1F,
left). In addition, PGC-1a/bf/f/MLC-Cre mice did not differ from
controls on ledge, platform (data not shown), or inverted screen
tests (Figure S1G, right). Thus, PGC-1a/bf/f/MLC-Cre mice do
not exhibit abnormalities in coordination, balance, or muscle
strength beyond the phenotype that can be attributed to gener-
alized PGC-1a deficiency.
PGC-1a/b Deficiency Uncouples Muscle Oxidative
Capacity from Fiber Type Determination
To further evaluate the basis for the exercise phenotype in PGC-
1a/bf/f/MLC-Cre mice, formal skeletal muscle fiber typing wasCell Metabolism 12, 633–642,conducted. First, fiber type distribution
was examined in GC muscle using meta-
chromatic ATPase staining under acidic
conditions, which are permissive for
myosin heavy chain 1 (MHC1) ATPase
activity, butnot forMHC2ATPase.Surpris-
ingly, analysis of the oxidative regions of
GC muscle demonstrated a mild increase
in numbers of MHC1-positive muscle
fibers in PGC-1a/bf/f/MLC-Cre muscles
compared to the other groups (Figure 2A).
We next performed quantitative immu-
nohistochemical analyses of fiber type
distribution in the muscle of the fourgenotypes. These studies were initially conducted on plantaris
muscle, which exhibits less regional heterogeneity in oxidative
fiber type compared with GC. Again, higher proportions of
MHC1-positive fibers were noted in PGC-1a/bf/f/MLC-Cre
muscle when compared with the other genotypes (Figure 2B).
Moreover, type IIa, IIx, and IIb fiber proportions were not different
among the groups (Figure 2B). Quantitative analysis of MHC
mRNA transcripts in GC muscle of PGC-1a/bf/f/MLC-Cre mice
revealed an increase in MHC1 mRNA levels in PGC-1a/bf/f
and PGC-1a/bf/f/MLC-Cre mice and a modest but significant
decrease in MHC2a and 2x mRNA levels in PGC-1a/
bf/f/MLC-Cre muscle (Figure S2). These latter results suggest that
posttranscriptional compensatory mechanisms may contribute
to the maintenance of normal type II fiber distribution in the
muscle of PGC-1a/bf/f/MLC-Cre mice.
We next assessed the oxidative capacity of the PGC-
1a/bf/f/MLC-Cre muscle. For these studies, activity of the mito-
chondrial enzyme succinate dehydrogenase (SDH) was usedDecember 1, 2010 ª2010 Elsevier Inc. 635
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Figure 3. PGC-1a–/–bf/f/MCK-Cre Muscle Exhibits a Mild Increase
in MHC1-Positive Fibers without a Change in Type II Fiber Formation
(A)RepresentativesectionsofGCandsoleusmuscle fromPGC-1a/bf/f/MCK-Cre
mice (see also Figure S3) stained for myosin ATPase activity.
(B) Quantification of IHC immunostaining studies expressed as mean percent
(± SEM) of total muscle fibers (n = 3–5/group). *p < 0.05 versus ab+/+; zp <
0.05 versus a/; #p < 0.05 versus b/.
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PGC-1 Actions in Skeletal Muscleas an endpoint. SDH activity staining was only minimally
reduced in PGC-1a/bf/f and PGC-1bf/f/MLC-Cre GC and soleus
muscle compared to PGC-1bf/f controls (Figure 2C). In striking
contrast, SDH staining was dramatically reduced in
PGC-1a/bf/f/MLC-Cre muscle (Figure 2C). Thus, PGC-1 coacti-
vators are required to maintain skeletal muscle oxidative
capacity but not fiber type determination.
The fiber typing studies described above only allowed us to
explore the effects of PGC-1a/PGC-1b deficiency in type II fibers
given the fiber specificity of MLC1f-Cre. To assess the effects of
combined PGC-1a/PGC-1b deficiency on type I fibers, PGC-
1a/bf/f mice were bred with mice expressing amuscle creatine
kinase (MCK) promoter-driven Cre (MCK-Cre) to establish the
PGC-1a/bf/f/MCK-Cre line, in which the PGC-1b gene is disrup-
ted in both fast- and slow-twitch muscle fiber types in a PGC-
1a-deficient background. As expected, expression of the
PGC-1b gene was significantly reduced in fast and slowmuscles
in PGC-1a/bf/f/MCK-Cre mice (Figure S3). As we found for the
PGC-1bf/f/MLC-Cre mice, PGC-1a mRNA levels were unchanged
in the muscle of the PGC-1bf/f/MCK-Cre mice (data not shown).
The PGC-1a/bf/f/MCK-Cre line also had significant reduction in
cardiac PGC-1b expression, which resulted in cardiomyopathy
by 1month of age (data not shown), a finding that was predicted,
given that cardiac PGC-1a/PGC-1b deficiency causes
postnatal heart failure (Lai et al., 2008). As observed in
PGC-1a/bf/f/MLC-Cre muscle, type I fiber type proportion was
slightly increased without changes in the relative proportions of
the other fiber types in PGC-1a/bf/f/MCK-Cre mice, based on
metachromatic staining and MHC immunohistochemistry per-
formed on soleus andGC sections (Figures 3A and 3B). Together636 Cell Metabolism 12, 633–642, December 1, 2010 ª2010 Elsevierwith the results obtained from the PGC-1a/bf/f/MLC-Cre mice,
these data strongly suggest that PGC-1a and PGC-1b are
dispensable for skeletal muscle development and fundamental
fiber type determination.
Mitochondrial Structural and Functional Derangements
in PGC-1a–/–bf/f/MLC-Cre Muscle
Transcriptional profiling studies were conducted using GC to gain
further insight into the alterations in PGC-1a/bf/f/MLC-Cre muscle.
We were particularly interested in the subset of genes that were
downregulated only in the doubly deficient mice. The number of
genes (array probes) that were downregulated uniquely or shared
by the three genotypes is displayed in the Venn diagram (Fig-
ure 4A). Of the 5526 genes that were downregulated in the PGC-
1a/bf/f/MLC-Cre, 2839 were uniquely downregulated compared
to the other two genotypes. In addition, 1086 genes were upregu-
lated in PGC-1a/bf/f/MLC-Cre muscle (data not shown).
Gene ontology (GO) analysis demonstrated that mitochondrial
pathways were rarely downregulated in singly PGC-1a- or PGC-
1b-deficient muscle (4/229 or 1.7% of total pathways). In
contrast, 47/202 (or 23%) of total pathways downregulated
only in the double knockout muscle were involved in mitochon-
drial processes, including the TCA cycle, electron transport,
OXPHOS, and mitochondrial membrane organization and
biogenesis (Table S1, shaded pathways). Only two pathways
were significantly upregulated in the double knockout, neither
of which was mitochondrial. Quantitative RT-PCR validation
studies were conducted on a subset of genes representative of
the latter pathways (identified as uniquely downregulated in the
PGC-1a/bf/f/MLC-Cre muscle). Levels of mRNA-encoding
enzymes involved in the TCA cycle (citrate synthase [Cs]), elec-
tron transport chain/OXPHOS (cytochrome oxidase subunit IV
isoform 1 [Cox4i1] and ATP synthase F1 complex beta subunit
[ATP5b]), mitochondrial membrane transport (adenine nucleo-
tide translocator 1 [Ant1]), and reactive oxygen species
scavenging (mitochondrial superoxide dismutase 2 [Sod2])
were downregulated in PGC-1a/bf/f muscle (and some in
PGC-1bf/f/MLC-Cre) and further reduced in PGC-1a/bf/f/MLC-Cre
muscle when compared to PGC-1bf/f controls (Figure 4B).
However, levels of mRNA encoding other enzymes, such as
those involved in fatty acid oxidation (carnitine palmitoyltransfer-
ase 1b [Cpt1b] and medium-chain acyl-coenzyme A dehydroge-
nase [Acadm]), was reduced in PGC-1a/bf/f muscle, but not
further downregulated in the double knockout muscle. Interest-
ingly, expression of the gene encoding nuclear respiratory factor
1 (NRF-1), a PGC-1a target (Wu et al., 1999) involved in regu-
lating OXPHOS genes and coordinating nuclear and mitochon-
drial genomes, was similar among the groups. This latter result
is consistent with the findings of a previous study showing no
effect of loss of PGC-1a on NRF-1 expression in the heart (Arany
et al., 2005) or skeletal muscle (Geng et al., 2010). Taken
together, the transcriptional profiling results indicate that a signif-
icant subset of PGC-1 target genes, particularly those involved in
mitochondrial energy transduction pathways, are shared by the
PGC-1 coactivators. It should also be noted that within the
shared target gene data set, loss of PGC-1a alone often had
a greater impact than PGC-1b deficiency (Figure 4B).
Further review of the gene expression array data revealed
that several genes involved in mitochondrial dynamics,Inc.
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Figure 4. PGC-1a and b Drive an Overlap-
ping Subset of Target Genes Involved in
Mitochondrial Processes
(A) Venn diagram displaying the results of gene
expression microarray analysis conducted on
RNA isolated from PGC-1a/bf/f (a/), PGC-
1bf/f/MLC-Cre (b/), and PGC-1a/bf/f/MLC-Cre
(ab/) GC muscle compared to PGC-1bf/f
controls. The numbers denote number of downre-
gulated gene probes (%0.7) in the corresponding
sector.
(B) Levels of mRNAs based on quantitative real-
time RT-PCR performed on RNA isolated from
GC muscle of 3- to 4-month-old male mice from
the genotypes indicated (n = 8–10 per group).
Citrate synthase, Cs; cytochrome c oxidase
subunit 4 isoform 1, Cox4i1; beta polypeptide of
the H+ transporting mitochondrial F1 complex
ATP synthase, Atp5b; adenine nucleotide translo-
cator 1, Ant1 = Slc25a4; mitochondrial superoxide
dismutase 2, Sod2; the muscle isoform of carni-
tine-palmitoyl transferase 1, Cpt1b; medium chain
acyl-CoA dehydrogenase, Acadm; and nuclear
respiratory factor 1, Nrf1. Bars represent mean
values (± SEM) normalized to 36B4 mRNA levels
and expressed relative (= 1.0) to PGC-1bf/f (ab+/+)
muscle. *p < 0.05 versus ab+/+; zp < 0.05 versus
a/; #p < 0.05 versus b/.
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PGC-1 Actions in Skeletal Muscleincluding fusion and fission, were also downregulated in
PGC-1a/bf/f/MLC-Cre muscle (GO ID 7006, 5741, 5743, 31966)
(Table S1). Validation studies confirmed that the expression of
mitofusin (Mfn) 1 and 2 genes and the gene encoding dyna-
min-related protein 1 (Drp1, dnm1l), a key mitochondrial fission
protein, was significantly downregulated in the muscle of the
PGC-1a/bf/f/MLC-Cre mice compared to the other groups (Fig-
ure 5A). These results suggested that the PGC-1 coactivators
are necessary for mitochondrial dynamics and quality control
in skeletal muscle. Therefore, mitochondrial volume density,
size, and ultrastructure were assessed by electron microscopy
in the intermyofibrillar (IM) and subsarcolemmal (SS) compart-
ments of theGCmuscle fibers of all four genotypes. This analysis
revealed striking mitochondrial morphologic abnormalities in IM
and SS regions in the PGC-1a/bf/f/MLC-Cre muscle compared to
the other genotypes, including a reduction in density and hetero-
geneity of size (Figure 5B and data not shown). The muscle mito-
chondria of PGC-1a/bf/f/MLC-Cre mice contained many small,
fragmented mitochondria juxtaposed to elongated, thin mito-
chondria (arrows, Figure 5B). Mitochondrial DNA levels were
reduced in parallel with the observed ultrastructural derange-
ments among the genotypes (Figure S4). Taken together, these
results implicate the PGC-1 coactivators in muscle mitochon-
drial biogenesis and fusion/fission programs.Cell Metabolism 12, 633–642,Respiration rates were determined on
mitochondria isolated from the hindlimb
of all four genotypes using pyruvate
or palmitoylcarnitine as substrates. Con-
sistent with the dramatic structural
derangements, state 3 respiration rates
were markedly reduced in PGC-1a/
bf/f/MLC-Cre muscle compared to the WTcontrols (Figure 5C). State 3 rates in mitochondria from single
PGC-1 gene-deficient muscle were reduced to a level midway
between the WT controls and that of PGC-1a/bf/f/MLC-Cre mice
(Figure 5C).
Muscle PGC-1a/b Deficiency Does Not Affect Glucose
Tolerance or Insulin Resistance
We next sought to assess glucose utilization and insulin respon-
siveness in the PGC-1a/bf/f/MLC-Cre mice. Mice of all four
genotypeswere subjected to glucose tolerance (GTT) and insulin
tolerance (ITT) testing. For initial studies on standard
chow, we compared results obtained with PGC-1bf/f and
PGC-1bf/f/MLC-Cre or PGC-1a/bf/f and PGC-1a/bf/f/MLC-Cre
so that littermate comparisons were possible. Neither the
muscle-specific PGC-1b-deficient (PGC-1bf/f/MLC-Cre) (Figure 6A)
nor the double knockout (PGC-1a/bf/f/MLC-Cre) (Figure 6B) line
exhibited glucose intolerance or insulin resistance when
compared with their respective controls. The studies were then
repeated after an 8 week high-fat-diet regimen to determine
whether this intervention would unveil a phenotype. As with stan-
dard diet, there was no difference in ITT or GTT among the geno-
types on the high-fat diet (Figure 6C). In addition, fasting levels of
glucose, insulin, free fatty acids, and triglycerides were not
different among the groups (Figure S5). Skeletal muscleDecember 1, 2010 ª2010 Elsevier Inc. 637
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Figure 5. PGC-1a–/–bf/f/MLC-Cre Muscle Exhibits Mitochondrial Struc-
tural and Functional Abnormalities and Dysregulation of Genes
Involved in Mitochondrial Dynamics
(A) Levels of mRNAs encoding mitochondrial fission and fusion genes,
including mitofusin 1 (Mfn1), mitofusin 2 (Mfn2), dynamin-related protein 1
(Drp1 or dmn1l), and mitochondrial outer membrane fission 1 homolog (yeast)
(Fis-1), determined by quantitative real-time RT-PCR (n = 7–8 per group). Bars
represent mean values (± SEM) normalized to 36B4 mRNA levels and
expressed relative (= 1.0) to PGC-1bf/f (ab+/+) muscle.
(B) Representative electron micrographs of gastrocnemius showing subsarco-
lemmal mitochondria in sections from PGC-1a/bf/f mice (a/; top row) and
PGC-1a/bf/f/MLC-Cre mice (middle row and magnified in bottom row). Note
small, fragmented (white arrowhead), and elongated (black arrowhead) mito-
chondria. Scale bars represent 500 nm.
(C) Bars represent mean (± SEM) mitochondrial respiration rates determined
onmitochondria isolated from the entire hindlimbmuscle of the four genotypes
shown using pyruvate or palmitoylcarnitine as a substrate (4–6 male animals
per group). Rates were measured under the following conditions: basal, state
3 (ADP-stimulated), and after oligomycin treatment (oligo-induced State 4).
*p < 0.05 versus ab+/+; zp < 0.05 versus a/; #p < 0.05 versus b/. See
also Figure S4.
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638 Cell Metabolism 12, 633–642, December 1, 2010 ª2010 Elseviertriglyceride levels were also similar among the four genotypes
(Figure S5).
To further evaluate muscle glucose utilization in the PGC-
1a/bf/f/MLC-Cre mice, glycogen levels were assessed pre- and
postexercise. For these experiments, the four genotype groups
were run for a duration matched to the time required for the
PGC-1a/bf/f/MLC-Cre mice to reach exhaustion. Baseline
glycogen levels in the GC did not differ between groups. The
bout of exercise rapidly depleted stores in PGC-1a/bf/f/MLC-Cre
mice but did not significantly change muscle glycogen levels in
the PGC-1bf/f, PGC-1a/bf/f, and PGC-1bf/f/MLC-Cre groups (Fig-
ure 7A). These results suggested that the PGC-1a/bf/f/MLC-Cre
muscle relies largely on anaerobic glycolysis for ATP production
during exercise. This conclusion is supported by the
observation that blood lactate levels increased markedly in the
PGC-1a/bf/f/MLC-Cremice followingaboutofexhaustiveexercise
compared to that of WT and PGC-1bf/f/MLC-Cre after exhaustive
exercise (Figure 7B). Blood lactate levels also increased in
the PGC-1a/bf/f mice, but to a lesser extent than the PGC-
1a/bf/f/MLC-Cre group. These results are consistent with the
observation of normal glucose tolerance and help explain the
severe exercise deficit, given that glucose derived from glycogen
serves as an obligate fuel source during exercise.
DISCUSSION
We devised a strategy to disrupt the PGC-1b gene in a skeletal-
muscle-selective manner in a generalized PGC-1a-deficient
mouse background. As described herein, we found that PGC-
1a and PGC-1b serve overlapping roles in skeletal muscle and
together are necessary for exercise performance (even minimal
exertion) and maintenance of mitochondrial structure and func-
tion, but are dispensable for fundamental fiber type determina-
tion and normal muscle insulin sensitivity and glucose disposal.
Our findings demonstrated that the cooperative and overlap-
ping actions of PGC-1a and PGC-1b are required for muscle
mitochondrial function and structure. Transcriptional profiling
studies revealed that the expression of a broad array of genes
involved in multiple mitochondrial energy transduction and
OXPHOS pathways is dependent on having at least one func-
tional PGC-1 gene. PGC-1a/b deficiency resulted in dramatic
derangements in mitochondrial structure and respiratory func-
tion, indicating that the PGC-1 coactivators are required for
maintaining a healthy population of normal mitochondria. This
latter function has been ascribed to the ongoing dynamics of
fusion and fission, which serve to maintain mitochondrial quality
control (Chen et al., 2005; Waterham et al., 2007; Zhang and
Chan, 2007). Consistent with this conclusion, we found that
the expression of genes involved in fusion (Mfn1, Mfn2)
and fission (Drp1) was downregulated in the muscle of
PGC-1a/bf/f/MLC-Cre mice compared to the other genotypes.
Others have recently shown that PGC-1a and PGC-1b are
capable of activating transcription of the Mfn2 gene by coacti-
vating the nuclear receptor ERRa (Soriano et al., 2006; Liesa
et al., 2008). Taken together, these results suggest that the
PGC-1 coactivators are necessary for maintaining high-level
coordinated expression of genes involved in mitochondrial
energy transduction and ATP production pathways, as well as
maintenance of a healthy population of muscle mitochondria.Inc.
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Figure 6. Global Loss of PGC-1a Combined
with Muscle-Specific Loss of PGC-1b Does
Not Result in Glucose Intolerance or Insulin
Resistance
(A) Mean blood glucose (± SEM) levels during GTT
(left) and ITT (right) using 2- to 3-month-old male
littermate PGC-1bf/f (ab+/+) and PGC-1bf/f/MLC-Cre
(b/) mice on standard chow as described in the
Experimental Procedures (n = 9–10). Total area
under the glucose excursion curve (± SEM) is dis-
played in the inset for the GTT.
(B) GTT and ITT results (mean blood glucose ±
SEM) for 2- to 3-month-old male littermate PGC-
1a/bf/f (a/) and PGC-1a/bf/f/MLC-Cre (ab/)
mice on standard chow (n = 11–13 per group).
(C) Results of GTT (left) and ITT (right), expressed
as mean blood glucose ± SEM, conducted on
13-week-old male mice after 8 weeks of high-fat
diet (n = 3–6/group). See also Figure S5.
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PGC-1 Actions in Skeletal MuscleThe impact of combined PGC-1a and PGC-1b deficiency on
exercise performance was dramatic. Our results strongly
suggest that the exercise phenotype is due to severe mitochon-
drial dysfunction forcing reliance on anaerobic glycolysis for ATP
production, leading to rapid depletion of glycogen and prema-
ture fatigue. The marked elevation in circulating lactate levels
in the PGC-1a/b-deficient mice postexercise is consistent with
this conclusion. Interestingly, lactate levels were also increased
postexercise in the PGC-1a/ mice, albeit to a lesser extent
than the PGC-1a/b-deficient animals. This latter observation
could reflect the fact that hepatic PGC-1a deficiency results in
an altered Cori cycle response. It is also possible that PGC-1 co-
activators play a primary role in glycogen metabolism. However,
the protein levels of the enzymes involved in glycogen synthesis
and degradation were not significantly altered in the PGC-
1a/bf/f/MLC-Cre mice (data not shown).
Surprisingly, combinedPGC-1a/bdeficiency results in a remark-
able uncoupling of muscle fiber type and oxidative programs.
Specifically, phenotypic analysis of the PGC-1a/bf/f/MLC-CreCell Metabolism 12, 633–642,mice did not reveal a shift toward a
‘‘detrained’’ muscle fiber type profile, as
would be predicted by PGC-1 overexpres-
sion studies. Rather, we found a modest
increase in type I fibers in the muscles of
both PGC-1a/bf/f/MLC-Cre and PGC-
1a/bf/f/MCK-Cre lines. The observed
increase in type I fibers in the mutant mice
suggests that an independent, currently
unidentified pathway involved in funda-
mental fiber type is compensatorily acti-
vated. PGC-1 overexpression in mice has
been shown to inhibit the protein degrada-
tion known to occur in disuse atrophy
(Wenz et al., 2009; Brault et al., 2010).
However, we did not find an overt abnor-
mality in muscle mass in the PGC-
1a/bf/f/MLC-Cre mice. Thus, whereas
PGC-1 coactivators are capable of driving
a shift toward oxidative fibers and musclegrowth, theyare not required for fundamentalmuscle development
or fiber type specification. One caveat to our conclusions is that
a small amount of a mutant form of a naturally occurring, alterna-
tively spliced form of PGC-1a, referred to as NT-PGC-1a (Zhang
et al., 2009), could be theoretically expressed in the PGC-1a-defi-
cient line used in this study. However, RT-PCR analysis demon-
strated that levels of this transcript are barely detectable inmuscle,
aswe have shown in the generalized PGC-1a-deficient line (Leone
etal., 2005).Moreover, given theseveremitochondrial andexercise
phenotype shown here, it would seem unlikely that this could
account for a completely normal fiber phenotype.
Significant evidence suggests a link between skeletal muscle
mitochondrial dysfunction and the development of insulin resis-
tance (Lowell and Shulman, 2005; Morino et al., 2005; Petersen
et al., 2005). In addition, several studies in humans have shown
reduced expression of PGC-1a (Mootha et al., 2003; Patti
et al., 2003) in skeletal muscle of insulin-resistant and diabetic
subjects. These studies implicate muscle mitochondrial
dysfunction and altered PGC-1 signaling in the pathogenesisDecember 1, 2010 ª2010 Elsevier Inc. 639
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Figure 7. Combined Loss of Skeletal Muscle PGC-1a and b Results
in Rapid Depletion of Muscle Glycogen during Exercise
(A) Mean glycogen levels (± SEM) of GCmuscle of sedentary 2- to 3-month-old
male mice of the indicated genotypes are shown on the left. The results of GC
glycogen levels postexercise are shown on the right.
(B) Mean blood lactate levels (± SEM) at baseline (white bars) and following
exhaustive exercise (black bars) for all four genotypes (n = 5–10/group).
(Run-to-exhaustion protocol is described in text and Experimental Proce-
dures.) *p < 0.05 versus ab+/+; zp < 0.05 versus a/; #p < 0.05 versus b/.
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PGC-1 Actions in Skeletal Muscleof insulin resistance. The studies shown herein demonstrate that
total skeletal muscle PGC-1 deficiency in mice does not lead to
insulin resistance or glucose intolerance on standard chow or
high-fat diet. Moreover, given the mitochondrial derangements
present in PGC-1a/bf/f/MLC-Cre muscle, our results suggest
that mitochondrial dysfunction is unlikely to contribute to insulin
resistance. It is certainly possible, however, that insulin resis-
tance drives muscle mitochondrial dysfunction.
EXPERIMENTAL PROCEDURES
Animal Studies
Generation of PGC-1bf/f mice has been described elsewhere (Lai et al., 2008).
PGC-1bf/f mice were crossed with mice expressing Cre under control of
a MLC1f promoter (Bothe et al., 2000) or the MCK promoter (Bru¨ning et al.,
1998) to achieve muscle-specific deletion of PGC-1b. These mice in turn
were crossed to obtain mice homozygous for the loss of PGC-1a (Leone
et al., 2005) and the PGC-1b flox allele (PGC-1a/bf/f mice), with and without
MLC1f-Cre. (See Supplemental Experimental Procedures for more detail
regarding the breeding strategy.)
Mice were maintained in the hybrid background, C57BL6/J x sv129, and
littermate controls were used. PGC-1bf/f and PGC-1bf/f/MLC-Cre mice were
generated from the same breeding pairs, while PGC-1a/bf/f and640 Cell Metabolism 12, 633–642, December 1, 2010 ª2010 ElsevierPGC-1a/bf/f/MLC-Cre mice were generated from a different set of breeding
pairs. Male mice were used for all experiments unless otherwise stated.
Mice were allowed ad libitum access to standard laboratory rodent chow
(diet 5053, Purina Mills Inc.) or high-fat diet (TD97268, Harlan Teklad) as indi-
cated. All animal experiments and euthanasia protocols were conducted in
strict accordance with the National Institutes of Health guidelines for humane
treatment of animals and were reviewed and approved by the Institutional
Animal Care and Use Committees of Washington University School of Medi-
cine and the Sanford-Burnham Medical Research Institute.
Glucose and Insulin Tolerance Testing
Prior to studies, 2- to 3-month-old male mice on standard chow were fasted
overnight (GTT) or for 6 hr (ITT). For GTT studies, mice were injected with
1 g/kg of D-glucose. For ITT, mice received an intraperitoneal injection of
human regular insulin (Eli Lilly and Co.) at a dose of 0.75 U/kg body weight
for ITT. The tip of the tail (1 mm) was cut 60 min prior to the glucose or insulin
challenge for blood sampling. Blood glucose levels were determined at several
different time points after challenge using an Accu-Chek Advantage glucome-
ter (Roche). For GTT, area under the curve (AUC) was defined as the difference
between baseline glucose levels and the deflection caused by the glucose
challenge. Total AUC was calculated using the trapezoidal rule. For the high-
fat-diet study, mice were given high-fat diet beginning at 5 weeks of age. At
13 weeks of age, GTT and ITT were performed following a 5 hr fast. A dose
of 2 g/kg D-glucose was used for the GTT.
Blood and Tissue Chemistry
After an 8 week high-fat-diet regimen, mice were fasted overnight (16 hr)
beginning at 5 p.m. Blood samples (1 ul) were obtained from the tail for
measurement of blood glucose using an Accu-Chek Advantage glucometer
(Roche). Additional blood (50 ul) was obtained for insulin measurements.
Plasma insulin levels were determined by ELISA (Mercodia, Inc.) following
the manufacturer’s instructions. Mice were euthanized by CO2 inhalation after
10 weeks on high-fat diet, and plasma and tissue triglyceride concentrations
were determined by colorimetric assays as previously described (Chen
et al., 2008). Plasma free fatty acids were also determined by a colorimetric
assay (Lin et al., 2002b).
Evaluation of Exercise Performance
Two- to three-month-old mice were run to exhaustion employing a motorized,
speed-controlled, modular treadmill system (Columbus Instruments). The
treadmill was equipped with an electric shock stimulus and an adjustable incli-
nation angle. Running velocity was set to 10 m/min for 1 hr and increased by
2 m/min increments every 15 min. The inclination angle was level. Tail blood
was taken before and immediately following the exhaustion point, and lactate
levels were analyzed using a Lactate Pro blood lactate test meter (ARKRAY,
Inc.). For the assessment of muscle glycogen and serum CK values, male
PGC-1a/bf/f/MLC-Cre mice were run to exhaustion, and the exercise
time of controls was matched to the running time of the respective PGC-
1a/bf/f/MLC-Cre mouse. Mice used for glycogen measurements were eutha-
nized immediately after the running bout while mice used for serum CK
measurements were harvested 30 min after the exercise bout. For details on
glycogen and CK measurements, see Supplemental Experimental
Procedures.
Evaluation of Muscle Function and Locomotor Activity
Muscle strength, muscle use, and general activity levels were assessed in 3- to
4-month-old female mice. For the assessment of forelimb grip strength, a grip
strength meter was used as previously described (Wozniak et al., 2007). (See
Supplemental Experimental Procedures for more detail.)
RNA, DNA, and Protein Analysis
Quantitative real-time PCR was performed on total RNA as previously
described (Huss et al., 2004). The mouse-specific primer-probe sets used to
detect specific gene expression can be found in Table S2. 36B4 mRNA was
measured in a separate well (in triplicate) and used to normalize the gene
expression data.
Genomic/mitochondrial DNA was isolated using the RNAzol method, fol-
lowed by back extraction with 4 M guanidine thiocyanate, 50 mM sodiumInc.
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PGC-1 Actions in Skeletal Musclecitrate, and 1 M Tris and an alcohol precipitation. Mitochondrial DNA content
was determined by SYBR Green analysis (Applied Biosystems or Stratagene).
The levels of NADH dehydrogenase subunit 1 (mitochondrial DNA) were
normalized to the levels of lipoprotein lipase (genomic DNA). The primer
sequences are noted in Table S2.
Gene Expression Profiling
The Digestive Diseases Research Core Center (DDRCC) Functional Genomics
Core Facility at Washington University School of Medicine performed hybrid-
ization of total RNA from GC muscle of 12-week-old mice to Agilent G4122F
Whole-Mouse Genome microarrays. Samples were hybridized in four experi-
mental pairs (PGC-1a/bf/f versus PGC-1bf/f, PGC-1bf/f/MLC-Cre versus PGC-
1bf/f, PGC-1a/bf/f/MLC-Cre versus PGC-1bf/f, and PGC-1a/bf/f/MLC-Cre
versusPGC-1a/) with threehybridizationsper pair. SeeSupplemental Exper-
imental Procedures for more detail.
Histology and Electron Microscopy
For electronmicroscopy (EM) analyses, adult mice were euthanized andmuscle
tissue was rapidly fixed with Karnovsky’s fixative (2% glutaraldehyde, 1%para-
formaldehyde, and 0.08%sodiumcacodylate). Musclewas dissected and post-
fixed in 1% osmium tetroxide, dehydrated in graded ethanol, embedded in Poly
Bed plastic resin, and sectioned for EM. EM was performed by the Research
Electron Microscopy Core at Washington University School of Medicine.
GC and soleus muscles were analyzed. Muscle tissue was formalin fixed
and embedded in paraffin, sectioned, and stained with hematoxylin and eosin
(H&E) and Masson’s Trichrome. For SDH and MHC ATPase stains, muscle
tissue was frozen down in isopentane that had been cooled in liquid nitrogen.
SDH stains were performed as described previously (Wende et al., 2007).MHC
ATPase stains were performed at pH 4.31. Under these acidic conditions,
MHC2 isoforms are inactivated while MHC1 is still functional, resulting in addi-
tion of black dye to MHC1-positive muscle fibers. Muscles for MHC immuno-
fluorescence (IF) analysis were embedded in OCT Compound (Tissue-Tek),
and IF was performed as described previously (Waters et al., 2004). The fibers
were quantified (MHC1, red; MHC2a, blue; MHC2x, black [unstained];
MHC2b, green), and results were expressed as relative numbers of the
different fiber types.
Mitochondrial Respiration
Mitochondrial respiration was assessed in isolated mitochondria from the hin-
dlimb muscle with pyruvate or palmitoylcarnitine as substrate, as described
previously (Bhattacharya et al., 1991). (See Supplemental Experimental Proce-
dures for more detail.)
Statistical Analysis
Data were analyzed using t tests or ANOVA where appropriate, with Newman-
Keuls tests or pairwise comparisons (Bonferroni adjusted) used for post hoc
analyses. The level of significance was set at p < 0.05 in all cases. Data are re-
ported as mean values ± SEM.
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The data discussed in this publication, including tables denoting the genes
significantly up- and downregulated in the PGC-1a/bf/f/MLC-Cre muscle,
have been deposited in NCBI’s Gene Expression Omnibus and are accessible
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